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Abstract
Background: Structural brain abnormalities have been investigated in multi-genetic and complex disorders such as
major depressive disorder (MDD). Among the various candidate genes implicated in MDD, the brain-derived
neurotrophic factor (BDNF) Val66Met polymorphism and 5-HT transporter gene linked polymorphism (5-HTTLPR)
have garnered the most attention due to their putative roles in neural plasticity and antidepressant response.
However, relatively few studies have assessed the influence of these polymorphysims on cortical thickness or brain
volume in para-limbic and limbic regions in MDD, which was the aim of this study.
Methods: Forty-three adults with MDD and 15 healthy controls (HC) underwent structural magnetic resonance
imaging (MRI). Cortical thickness was assessed in frontal, cingulate and temporal regions. Volumetric measures were
carried out in the thalamus, caudate, putamen, pallidum, hippocampus and amygdala. Participants were genotyped
to determine their 5-HTTLPR (tri-allelic) and Val66Met polymorphisms.
Results: In the combined sample (MDD + HC), smaller right pallidum volumes were found in LA/S (LA/S & LA/LG)
heterozygotes compared to S/S (S/S, LG/S & LG/LG) homozygotes, though the effect was modest. In the MDD
group, larger left thalamus and putamen volumes were observed in LA/LA homozygotes. No Val66Met or 5-HTTLPR
genotype effects existed on cortical thickness and no main effects of the Val66Met polymorphism were observed.
Conclusion: Our preliminary results suggest that the 5-HTTLPR polymorphism is associated with morphometric
changes in regions known to play an important role in emotional and reward processing in depression. A larger
sample size is required to replicate these findings and to potentially reveal subtle morphometric changes.
Keywords: Cortical thickness, Structural volume, Depression, Val66Met, 5-HTTLPR, Polymorphism
Background
The etiology of major depressive disorder (MDD) is com-
plex - encompassing social, environmental, physiological
and genetic factors. While accumulating data indicate that
no single gene is substantially implicated in increasing
MDD risk [1], two genes that have been extensively stud-
ied and linked with the disorder include those related to
the expression of brain-derived neurotrophic factor
(BDNF) and the serotonin transporter (5-HTT). Inter-
mediate phenotypes, such as abnormalities in brain
structure/morphometry, can be conceptualized as mani-
festations linking genetic factors and overt disorder indi-
ces. The majority of research has focused on examining
volumetric changes in para/limbic structures, such as the
hippocampus [2], in MDD; cortical thickness assessments
in MDD are less common. However, cortical thickness,
which reflects neuronal size, density and arrangement, as
well as those of neuroglia and nerve fibers, can provide
unique information about disorder-specific neuroanatom-
ical features [3]. Given that regional cortical thickness has
been linked with specific cognitive domains [4], and
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allowing for the possibility that subtle cortical thickness
changes may be easier to capture than gross structural
volume measures, a more thorough assessment of this
metric in the context of mental illness is warranted.
Accumulating evidence suggests that depressed adults
(including elderly depressed individuals) tend to exhibit
diffuse cortical thinning, including in frontal regions
[medial orbitofrontal (OBF) cortex, dorsolateral prefrontal
cortex (DLPFC)], insula, cuneus, posterior cingulate and
middle temporal cortices [5–12], though exceptions exist
[13, 14]. On the other hand, although we previously noted
thinner transverse temporal cortices, we also found
thicker frontal pole cortices in depressed adults [15]. An-
other group also reported thicker cortices in the right
frontal lobe (medial OBF, pars opercularis, rostral middle
frontal gyrus) and supramarginal gyrus in treatment-naïve
adults with first-episode MDD [3]. A handful of studies in
pediatric/adolescent MDD have reported both cortical
thinning (e.g. pericalcarine, post-central, superior parietal/
supramarginal gyrus regions) and thickening (e.g. tem-
poral poles, middle frontal gyrus, caudal cingulate gyrus)
[16, 17]. Work by our group and others suggest that
factors such as age of MDD onset and trauma history may
effect cortical thickness [5, 15]. Genetic influences on cor-
tical thickness in MDD, however, have scarcely been
examined.
Val66Met polymorphysim: influence on brain architecture
Most research has focused on the influence of the valine
(Val)-to-methionine (Met) substitution at codon 66
(Val66Met) in the BDNF gene; this polymorphysim is
believed to affect BDNF intracellular trafficking and de-
crease activity-dependent secretion [18]. Met allele car-
riers appear to be at greater risk for MDD development
when exposed to stressful life events [19]. Further, con-
verging data suggest decreases in hippocampal volumes
in Met (vs. Val/Val) allele carriers in both controls and
MDD patients [20–25] (but see [26, 27]), though one
group found that this was driven by the MDD cohort
[28] while another reported that this was mediated by
childhood adversity [29]. Volumetric decreases in rela-
tively diffuse brain regions have also been reported in
non-depressed Met (vs. Val/Val) carriers [30–32]. How-
ever, the role of the Val66Met polymorphisms on non-
hippocampal volumetric brain changes and cortical
thickness in the context of MDD remains unclear.
5-HTTLPR polymorphysim: influence on brain architecture
In comparison to the Val66Met polymorphism, research
on the role of the base-pair repeat polymorphism in the
promoter region of the 5-HTT (5-HTTLPR) in MDD is
more extensive. The 5-HTTLPR polymorphism lies in
the promotor region of the 5-HTT encoding gene
(SLC6A4), with a 44 base-pair (bp) insertion/deletion
generating two 5-HTTLPR alleles: S (14 bp repeats) and L
(16 bp repeats) [33]. Further, an A/G nucleotide substitu-
tion in the L allele (rs25531) renders the 5-HTTLPR tri-
allelic (LG/LG, LG/LA, LA/LA); the LG is purported to be
functionally similar to the S allele [34]. Studies suggest that
the L (vs. S) allele may have higher transcriptional activity,
which affects synaptic 5-HT clearance [35]. A complex rela-
tion appears to exist between the 5-HTTLPR polymorph-
ism and MDD risk, with S (vs. L) allele carriers having a
greater risk for MDD development in the context of adver-
sity [36]. Surprisingly little research has examined the
effects of the 5-HTTLPR polymorphism (tri- or diallelic)
on cortical thickness/brain morphometry.
Existing data on 5-HTTLPR polymorphism effects on
brain morphometry are mixed. Frodl et al., found grey
matter decreases in LA/LA MDD patients in the amydgala,
hippocampus, anterior cingulate cortex (ACC) and as-
pects of the dorsomedial PFC and DLPFC; in controls, the
opposite was found [37]. On the other hand, when using a
diallelic classification, another group reported smaller
hippocampi in S/S MDD patients (vs. controls); no differ-
ences existed between controls and patients who were S/L
heterozygotes or L/L homozygotes [38]. However, this re-
lation may be sex-dependent as others noted that non-
depressed S allele carrying females had larger hippocampi
than L/L females while the opposite was found in males
[39]. With respect to other brain regions, Selvaraj et al.,
reported reduced gray matter volumes in the inferior
frontal gyrus, ACC and superior temporal gyrus in non-
depressed S allele carriers relative to L/L homozygotes
[40]. Yet another, however, found that S allele carriers ver-
sus L/L homozygotes had greater amygdala volumes irre-
spective of diagnosis (MDD or control) [41]. Finally, a
handful of studies have assessed the putative interactive
(epistasis) effects between the Val66Met and 5-HTTLPR
polymorphisms on brain structure; existing data suggest
that the relationship is complex and cannot be deduced
from the independent effects of the two genes [26, 42, 43].
Study aims and hypotheses
In this study, we assessed the effects of Val66Met and 5-
HTTLPR polymorphisms (tri-allelic classification) on cor-
tical thickness in cingulate, frontal and parahippocampal
regions as well as the insula – areas most-consistently
modulated by these polymorphysims. This is an extension
of previous work in the same cohort where we found
thicker frontal poles and thinner transverse temporal gyri
in MDD compared with control groups [15]. We also
assessed the influence of Val66Met and 5-HTTLPR poly-
morphisms on para/limbic structures (thalamus, caudate,
putamen, pallidum, hippocampus and amygdala). To
maximize power, and given the paucity of data on the ef-
fects of genetic polymorphisms on cortical thickness, all
analyses were first carried out on groups (MDD and
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control) collapsed. Exploratory analyses (due to the
limited sample sizes in specific allele groups) were then
carried out on the MDD group; this was not possible in
controls due to the small sample size.
Consistent with previous work, we expected smaller
hippocampal volumes in Met allele (vs. Val/Val) carriers.
We expected volumetric reductions in other para/limbic
structures as well as cortical thickness decreases in Met
carries, which would be more pronounced in the MDD
cohort. Given the mixed data regarding the influence of
the 5-HTTLPR polymorphism on brain architecture, dir-
ectional hypotheses with respect to this polymorphism
were difficult to make. However, it is possible that LA/LA
homozygotes would exhibit thickest cortices and greatest
structural volumes, though this may not necessarily be
true in the MDD cohort.
Methods
Participants
Consistent with previous work [15], 43 adults with a pri-
mary MDD diagnosis were recruited (Structured Clinical
Interview for DSM IV-TR Diagnoses [SCID]-assessed). All
patients had a Hamilton Rating Scale for Depression
(HAMD17) score of ≥18 [44]. Notable exclusion criteria
were: bipolar or anxiety disorder diagnosis (sub-threshold
anxiety was not an exclusion criterion), psychosis history,
current (<6 months) substance abuse/dependence, neuro-
logical or eating disorders, unstable medical condition,
significant suicide risk and magnetic resonance imaging
(MRI) contraindications. Participants were free of psycho-
tropic drugs for at least three weeks at the time of neuro-
imaging. Fifteen healthy controls with no psychiatric
history were also tested. Informed consent was obtained
from all participants in accordance with the Conjoint
Health Research Ethics Board at the University of Calgary.
Magnetic resonance imaging (MRI)
Images were collected at the Seaman Family MR Centre
(Foothills Hospital, University of Calgary) with a 3 T Gen-
eral Electric scanner (Signa LX, Waukesha, WI, USA) using
an eight-channel head coil. A T1-weighted magnetization
prepared rapid acquisition gradient echo (MPRAGE) image
was acquired (TR = 8.3 ms; TE = 1.8 ms; flip angle = 20°;
voxels = 0.5 × 0.5 × 1 mm; 1 mm slice thickness; 176 slices).
Cortical thickness & automatic segmentation
Cortical thickness analyses were carried out using Free-
Surfer software (http://surfer.nmr.mgh.harvard.edu), as
previously described [15]. Briefly, T1 images were
intensity-normalized, after which a skull-stripping pro-
cedure was applied. Images were segmented using an es-
timation of the structure of the grey-white interface.
Each scan was covered with a triangular tessellation and
inflated (for a smooth spherical representation of the
grey-white interface and pial surface). Inflated scans were
aligned to FreeSurfer’s default reference template via a 2D
warp based on cortical folding patterns. Once smoothed
(circularly symmetric Gaussian kernel), sulci and gyri
curvature patterns were aligned and average cortical thick-
ness was measured at each surface point. A uniform
surface-based spherical coordinate system was created by
transforming the reconstructed surfaces into parameteriz-
able surfaces. An averaging procedure (50 iterations) was
applied to smooth the surface and the reconstructed pial
surface was refined with a deformable surface algorithm.
Data was again aligned on a common spherical coordinate
system. Cortical thickness was determined by measuring
and averaging the distance between the grey/white matter
boundary and pial surfaces. The following regions were
assessed: a) cingulate regions (rostral anterior cingulate,
caudal anterior cingulate, posterior cingulate and isthmus
cingulate in both hemispheres), b) PFC/orbital regions
(frontal pole, lateral and medial OBF as well as parsorbitalis
cortices in both hemispheres), c) fronto-lateral regions (su-
perior frontal, rostral middle frontal, parsopercularis, par-
striangularis and caudal middle frontal cortices in both
hemispheres), d) parahippocampal regions (entorhinal and
parahippocampal cortices in both hemispheres) and e) the
insula (in both hemispheres).
FreeSurfer was also used to obtain subcortical volume
measures. A detailed description of the segmentation pro-
cedure can be found elsewhere [45]. Briefly, a training set is
used to generate a probabilistic brain atlas that acts as a
template used to assign labels to each voxel in an image.
This probabilistic atlas estimates the probability with which
particular structures are located throughout the brain, and
acts as a Bayesian prior that can be used to assign structure
labels to each voxel. Along with the probabilities given by
the atlas, structures are also distinguished by assessing
image intensity for specific tissue classes and the spatial lo-
cation in relation to other structures. Volumetric assess-
ments were carried out on the following: thalamus proper,




Either a 484 or 528 bp fragment was generated using a
forward 5′-GGCGTTGCCGCTCTGAATGC and reverse
5′-GAGGGACTGAGCTGGACAACCAC primer [46].
Genes were amplified using AccuPrime GC-Rich DNA
polymerase (Invitrogen, Carlsbad, CA, USA). The 25 μL
amplification mixture contained 100 ng of genomic DNA,
0.2 μM of each primer, 1U of AccuPrime GC-Rich DNA
polymerase and 1X AccuPrime GC-Rich Buffer A. The
cycling conditions were: a) initial denaturation at 95 °C for
3 min followed by 7 cycles at 95 °C for 30 s, 68 °C for 30 s
and 72 °C for 1 min; b) 7 cycles at 95 °C for 30 s, 67 °C for
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30s and 72 °C for 1 min; c) 7 cycles at 95 °C for 30s, 66 °C
for 30 s and 72 °C for 1 min. Final extension was at 72 °C
for 10 min. The final uncut product was run on 1.5 %
agarose gel at 50 V for 90 min; 12 μL of the PCR product
was then cut using the restriction enzyme MspI (New
England Biolabs Inc., Boston, MA, USA) for 3 h at 37 °C
[47]. To separate bands, the cut product was run on a 4-
20 % Tris/Borate/EDTA (TBE) gel at 14 mA for 100 min
(Invitrogen, Carlsbad, CA, USA). The 5-HTTLPR is a
44 bp deletion in the promoter region at bp 1212–1255
(chromosome 17), resulting in a short (S) or long (L)
allele. Within the extra 44 bp associated with the L allele,
there is also a guanine to adenine polymorphism, resulting
in LG and LA. The band pattern for LA was 340 bp, LG
was 166 + 174 bp and S was 297 bp [47].
Val66Met
A 113 bp fragment was amplified using a forward 5′-G
AGGCTTGACATCATTGGCT and reverse primer 5′-C
GTGTACAAGTCTGCGTCCT [48]. The 25 μL amplifi-
cation mixture contained 50 ng of genomic DNA,
0.2 μM of each primer and 1X AccuStart Taq DNA poly-
merase (Quanta Biosciences, Gaithersburg, MD, USA).
The cycling conditions were: a) initial denaturation at
95 °C for 2 min; b) 35 cycles at 94 °C for 30 s; c) 60 °C
for 30 s; d) 72 °C for 30 s; e) final extension following
the completion of the cycles at 72 °C for 5 min [49]. The
7.5 μL PCR product was cut with the restriction enzyme
Eco 721 (Fermentas, Glen Burnie, MD, USA) for 3 h at
37 °C. The bands were separated using a 4-20 % TBE gel
(Invitrogen, Carlsbad, CA, USA) at 14 mA for 60 min.
The resulting banding pattern for the methionine and
valine allele was 113 bp and two bands at 78 and 35 bp,
respectively.
Statistical analyses
MDD and Control groups were compared on clinical/
demographic variables using one-way analyses of variance
(ANOVAs) and Chi Square tests.
For the entire sample (MDD+Controls; N = 58), separ-
ate multivariate analyses of covariance (MANCOVAs;
group as covariate) were carried out to assess the effects
of genotype [Val66Met polymorphism: a) Val homozy-
gotes (Val/Val) & b) Met allele carriers (Met/-); 5-
HTTLPR polymorphysim: a) LA/LA b) S/S (includes LG/S,
LG/LG & S/S carriers) & c) LA/S (includes LA/LG & LA/S
carriers) on cortical thickness in distinct regions. Specific-
ally, MANCOVAs (separate MANCOVAs for Val66Met
and 5-HTTLPR polymorphisms) were carried out on cor-
tical thickness in 5 pre-specified regions (cingulate; PFC/
orbital; fronto-lateral; parahippocampal; insula). An omni-
bus MANCOVA, where all 32 sub-regions were included
as dependent variables, was also carried out. However,
given that the separate MANCOVAs for each of the 5
regions were of primary interest (due to region-specific hy-
potheses), the omnibus MANCOVA was followed by the 5
separate MANCOVAs, regardless of statistical significance.
Exploratory MANOVAs (as above, no group covariate)
were carried out for the MDD group only (N = 43). Signifi-
cant MANCOVAs/MANOVAs (p < .05, as well as trends:
p < .1) were followed-up with univariate ANCOVAs/ANO-
VAs. Assessment of interactions between the Val66Met and
5-HTTLPR genotypes was not possible due to the small
sample sizes for certain genotypes.
Finally, secondary one-way ANOVAs were also carried
out to explore the effect of genotype on clinical variables
only in the MDD group, namely HAMD17 scores, age of
MDD onset or duration of the current depressive episode.
Results
Participant characteristics
There was a trend for an age difference (p = .051) but no
differences in the distribution of sexes or genotypes be-
tween the MDD and control groups (Table 1). The
addition of age as a covariate did not alter the morpho-
metric findings (outlined below), as such, it was not in-
cluded in the analyses presented (data not shown). The
overall genotype frequencies of the Val66Met polymorph-
ism (Val/Val = .78, Val/Met = .21, Met/Met = .017) were
within the Hardy-Weinberg equilibrium (Chi2 p = .85).
The overall genotype frequencies of the 5-HTTLPR
polymorphism (LA/LA = .23, LA/LG = .07, LG/S = .07, LA/S
= .404, S/S = .23) were also within the Hardy-Weinberg
equilibrium (Chi2 p = .92). No differences existed on
demographic variables between the genotypes (data not
shown). Additionally, no differences were noted on clinical
variables in the MDD group based on Val66Met or 5-
HTTLPR polymorphisms.
Effect of 5-HTTLPR alleles on cortical thickness & volumes
of limbic structures
The omnibus MANCOVAs (all 32 sub-regions included as
dependent variables) yielded no effect of 5-HTTLPR geno-
type on cortical thickness when MDD and control groups
were collapsed [λ(62,44) = .76, p = .84]. Similarly, MANCO-
VAs were insignificant, when groups were collapsed, with
respect to 5-HTTLPR genotype on cortical thickness
within cingulate [λ(16,90) = .42, p = .98], parahippocampal
[λ(8,98) = .87, p = .55], PFC/orbital [λ(16,90) = .87, p = .61],
fronto-lateral regions [λ(20,86) = .97, p = .50] or the insula
[λ(4,102) = 1.05, p = .34]. The omnibus MANOVA for 5-
HTTLPR genotype on cortical thickness (i.e., all regions
included) for the MDD group was significant [λ(62,18) =
2.85, p = .01], however, none of the follow-up univariate
ANOVAs (for all 32 sub-regions) were found to be sig-
nificant. Further, none of the 5 MANOVAs assessing
cortical thickness per region were significant (cingulate
[λ(16,62) = .45, p = .96], parahippocampal [λ(8,70) =
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1.65, p = .13], PFC/orbital [λ(16,62) = 1.12, p = .36],
fronto-lateral regions [λ(20,58) = .91, p = .58] or the in-
sula [λ(4,74) = 1.03, p = .37]).
A weak trend for a significant MANCOVA was noted
for 5-HTTLPR genotype on para/limbic structure volume
when groups were collapsed [λ(24,86) = 1.44, p = .1].
Follow-up univariate ANOVAs yielded a main effect of 5-
HTTLPR genotype on the right pallidum [F(2,54) = 3.43,
p = .04], with a smaller volume in the LA/S heterozygotes
versus the S/S homozygotes (p = .016; Additional file 1:
Table S1A).
A significant omnibus MANOVA was noted for 5-
HTTLPR genotype on para/limbic structure volume for
the MDD group [λ(24,56) = 1.93, p = .02]. Univariate
ANOVAs yielded a main effect of 5-HTTLPR genotype
on the left thalamus proper [F(2,41) = 6.47, p = .004] and
left putamen [F(2,41) = 4.83, p = .013]. Follow-up compari-
sons indicated that the left thalamus proper was greater
for LA/LA homozygotes (N = 8; 8168.50, SD = 1407.38)
compared with LA/S heterozygotes (N = 20; 6982.80, SD =
801.95; p = .005; Fig. 1). LA/LA homozygotes (N = 8;
6805.38, SD = 934.92) also had a greater left putamen vol-
ume than S/S homozygotes (N = 14; 5691.57, SD = 879.75;
p = .004) and LA/S heterozygotes (N = 20; 6107.90, SD =
700.34, p = .046; Fig. 2; Additional file 1: Table S1B).
Effects of BDNF Val/66/Met polymorphisms on cortical
thickness and volumes of limbic structures
The omnibus MANCOVA (all sub-regions included as
dependent variables) yielded no effect of the Val66Met
polymorphism (N = 13 Met/-; N = 45 Val/Val) on cortical
thickness when groups were collapsed [λ(31,24) = .47,
p = .98]. Similarly, the MANCOVAs were insignificant
for the effects of the Val66Met polymorphism on cortical
thickness in any of the five regions examined, when groups
were collapsed [cingulate [λ(8,47) = .62, p = .76], pa-
rahippocampal [λ(4,51) = .70, p = .55], PFC/orbital
[λ(8,47) = .52, p = .84], fronto-lateral regions [λ(10,45) = .69,
p = .73], insula [λ(2,53) = 0.03, p = .88]. The omnibus
MANOVA for Val66Met polymorphism effects on cor-
tical thickness (all sub-regions) for the MDD group only
was insignificant [λ(31,10) = .46, p = .95]; MANOVAs
assessing cortical thickness per region were also insig-
nificant (p values > .1).
The MANCOVA also yielded no Val66Met polymorph-
ism effects on the volumes of para/limbic structures when
groups were collapsed [λ(12,44) = .43, p = .94; Additional
file 2: Table S2A). No effect of the Val66Met polymorphism
on para/limbic structure volumes existed for the MDD
group either [λ(12,30) = .35, p = .97]; exploratory assess-
ments indicated no polymorphism differences in the
hippocampus, where differences were hypothesized
(p = .77, left hippocampus; p = .70, right hippocam-
pus; Additional file 2: Table S2B).
Table 1 Characteristics of major depressive disorder (MDD) and healthy control (HC) groups
Characteristics MDD HC
N 43 15
Sex (F/M) 26/17 8/7
Age (yrs.) 30.3 ± 8.1 36.6 ± 11.1
5-HTTLPR polymorphysima LA/LA homozygotes = 8; S/S homozygotes = 14;
S/LA heterozygotes = 20
LA/LA homozygotes = 5; S/S homozygotes = 3;
S/LA heterozygotes = 7
Val66Met Val/Val homozygotes = 35; Met/- carriers = 8
(Met/Met = 1; Val/Met = 7)
Val/Val homozygotes = 10; Met carriers = 5
Baseline HAMD17 21.4 ± 4.2 -
Duration of current MDE (yrs.) 4.4 ± 5.2 -
MDD onset (yrs.) 24.5 ± 10.9 -
HAMD17Hamilton depression rating scale, MDD major depressive disorder
Means ± SDs presented
aS/S homozygotes: S/S, LG/S & LG/LG; S/LA heterozygotes: LA/S & LA/LG
Fig. 1 Greater (*p < .05) left thalamus proper volume in LA/LA
homozygotes versus S/LA (LA/S or LA/LG) heterozygotes in the
depressed cohort
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Discussion
This study examined the influence of 5-HTTLPR and
Val66Met polymorphisms on cortical thickness in regions
involved in emotion processing and cognitive control as
well as para/limbic structure volumes in depressed indi-
viduals and healthy controls. No 5-HTTLPR genotype ef-
fect was found on cortical thickness in the examined
regions when groups were collapsed or when only the
MDD group was examined. A 5-HTTLPR genotype effect,
however, existed on right pallidum volumes, with slightly
smaller volumes in LA/S heterozygotes versus S/S homo-
zygotes across the entire sample (a similar trend was
noted compared with LA/LA homozygotes: LA/S < LA/LA).
More robust findings were greater left thalamus proper
and putamen volumes in depressed LA/LA homozygotes.
No Val66Met polymorphism effects existed on cortical
thickness in any of the examined regions or on para/lim-
bic structure volumes.
Cortical thickness and genotypes
Although a handful of studies have examined the effects of
5-HTTLPR polymorphisms on grey matter volume/density
and structural volume, no studies, to our knowledge, have
systematically assessed the effects of 5-HTTLPR polymor-
phisms on cortical thickness in MDD, and only a few have
done so in non-depressed populations. We found no effect
of 5-HTTLPR genotype on cortical thickness in our sample.
This is consistent with the null results of another group
that assessed the association between 5-HTTLPR genotype
and cortical thickness in the ventrolateral and medial PFC
in healthy females, although they did find an association
between cortical thickness and biased attention to emotive
cues, which interacted with genotype [50]. Another group,
however, found a thinner ACC in healthy, non-depressed
female S/S homozygotes compared with female L/L homo-
zygotes and S/L heterozygotes in both females and males
[51]. The latter study, however, had a larger sample (>100
participants), which allowed for the evaluation of gender
influences.
We also found no Val66Met polymorphism effects on
cortical thickness, consisted with results by another group
in non-depressed adults [52]. However, others have noted
greater grey matter density/volume across diffuse brain re-
gions in Val/Val versus Met allele carriers [53], though
predominantly in frontal regions ([30, 31, 54] but see
[24]). Notably, the relation between the Val66Met poly-
morphism and cortical thickness may be influenced by
factors such as past trauma [32, 55] and age [52].
Despite our negative findings, it is not possible to rule
out the role of polymorphisms on cortical thickness in
MDD (and general population). However, a larger cohort
is required as these influences may be subtle. In our previ-
ous study using a comparable sample, childhood trauma
was shown to effect cortical thickness [15], suggesting that
early adversity may play a greater role on brain morphom-
etry than Val66Met and 5-HTTLPR polymorphisms. As
our sample was limited, we were underpowered to assess
the interaction between genotype and past trauma on cor-
tical thickness and volumetric measures in the current
study; though this is certainly worthy of investigation.
Additionally, a larger cohort would allow for the assess-
ment of possible interactive effects between MDD features
and subtypes, age and sex with genotype (epigenetic
effect) as well as gene-by-gene interactions (epistasis) on
cortical thickness.
Subcortical structural volumes and genotypes
We found slightly smaller right pallidum volumes in LA/S
(LA/S, LA/LG) heterozygotes versus S/S (S/S, S/LG, LG/LG)
homozygotes when MDD and healthy control groups were
collapsed. Previously, S/L heterozygotes have been shown
to exhibit increased white matter lesions in geriatric depres-
sion and lower central 5-HTTavailability [35, 56]. However,
to our knowledge, no published data on 5-HTTLPR poly-
morphism effects on pallidum structure exist, thus, our
findings require independent replication. The ventral palli-
dum is a convergent point of several brain areas implicated
in reward and cognitive processing (e.g. OBF, PFC and
infralimbic cortex, amygdala, hypothalamus, ventral teg-
mental area); its outputs re-enter corticolimbic loops via
the medial PFC and thalamus (which then relay projections
to the PFC). As such, the ventral pallidum is implicated in
regulating motivation and reward – domains of frequent
study in the context of MDD [57]. While untangling why
altered 5-HTT expression may be associated with pallidal
Fig. 2 Greater (*p < .05) left putamen volumes in LA/LA
homozygotes versus both S/LA (LA/S or LA/LG) heterozygotes and S/
S (S/S, LG/S, LG/LG) homozygotes in the depressed cohort
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volume alterations is difficult, 5-HT transmission has been
shown to play a neuromodulatory role in the ventral palli-
dum (5-HTT expression differences may thus alter pallidal
function and, ultimately, its structure). Although the ventral
pallidum largely consists of cholinergic and GABAergic
neurons, dorsal raphe 5-HT projections modulate their
transmission (likely via 5-HT1B/1A receptors [58]). However,
the involvement of the 5-HT system in the pallidum war-
rants further study.
It is somewhat surprising that we found no other 5-
HTTLPR polymorphism effects on other para/limbic struc-
tures when groups were collapsed, as previous studies re-
port volumetric changes in the amygdala and hippocampus
in relation to the polymorphism. However, these data are
mixed, with some groups noting greater amygdala volumes
in S/S homozygotes or S allele carriers [41, 51], while others
have found the opposite, with S allele carriers (vs. L/L ho-
mozygotes) exhibiting smaller volumes [37, 59, 60]. While
methodological differences (e.g. segmentation methods;
structural boundaries) may account for some of these
differences, other factors likely play a role – participant
ethnicity, mental health status and gender all appear to
contribute to the relation between genetics and brain
morphometry. Similar explanations may account for the
variable reports with respect to the influence of the 5-
HTTLPR polymorphysim on hippocampal volume [37–39].
While it is feasible that an 5-HTTLPR polymorphism effect
on hippocampus and amygdala volume may have emerged
with a larger sample, our null findings are consistent with
others [61–63].
When the MDD group was assessed separately, a larger
left thalamus proper were found in depressed LA/LA
homozygotes versus S/L heterozygotes. Our findings are
inconsistent with those of Young et al., who reported an
enlarged thalamus in S/S homozygotes (though, in the
depressed cohort, thalamic volume increases existed in-
dependent of genotype) [64]. Midline thalamic regions
have dense 5-HTT-containing fibers, as such, it is feas-
ible that 5-HTTLPR modulations would affect the
neural environment and, by extension, thalamic morph-
ometry [65]. The thalamus plays an important role in
regulating the expression and experience of emotion
and has been implicated in MDD pathophysiology [64],
however, the interactive effect between 5-HTTLPR
polymorphism and MDD on the volume of thalamus,
requires further study.
Similarly, a main effect of 5-HTTLPR genotype existed
on the left putamen in the MDD cohort, with greatest
volumes in depressed LA/LA homozygotes. Though
preclinical work suggests that the major input to the
caudate-putamen is dopaminergic, it is also receives 5-HT
projections [66]. Interestingly, greater 5-HTT densities in
the putamen of healthy Caucasian LA/LA homozygotes
have been found [47]. This supports the idea that 5-HT
function modulations by virtue of the genotype could in-
fluence both the activity and the structure of the putamen.
Radua et al., found that right putamen grey matter volume
was smaller in healthy individuals who were both COMT-
Met and 5-HTTLPR S allele carriers, or both COMT-Val
and 5-HTTLPR L/L homozygotes [61]. Another group
found that in healthy individuals, the number of daylight
minutes correlated negatively with 5-HHT expression in
the putamen but only in S allele (not L/L) carriers. This
suggests that S allele carriers may be more likely to exhibit
dynamic changes in 5-HT activity/turnover, which may be
associated with putamen volume changes [67]. Given the
volumetric changes observed in depressed LA/LA homozy-
gotes, future studies may wish to examine the prognostic
implications of this polymorphism.
Contrary to our hypotheses, we found no Val66Met
polymorphism effects on hippocampal volume. Given that
most evidence suggests decreased hippocampi in Met al-
lele carriers (vs. Val/Val homozygotes) in both healthy
controls and MDD patients [20–24], we expected compar-
able findings. With the exception of the Cardoner et al.,
(2013) study, however, all of the other studies consisted of
100+ participants, as such, it is possible that our compara-
tively small sample prevented the emergence of group
differences. Additionally, we used an automatic segmenta-
tion approach, which may have also contributed to our
null results [25]. Finally, a notable number of studies have
found no hippocampal differences in relation to Val66Met
polymorphisms [26, 27].
Despite the fact that this study is among the first to as-
sess 5-HTTLPR and Val66Met polymorphisms effects
on cortical thickness and para/limbic structure volume
in depressed individuals, certain study limitations must
be acknowledged. First, our sample was modest. This
prevented us from assessing polymorphism interactions,
the putative contribution of gender (and other factors,
e.g. age of depression onset and childhood abuse history,
and their possible moderating effects) on brain morph-
ometry as well as examining polymorphism effects in
the control group; such analyses are recommended in
comparable future work. Furthermore, although we only
followed-up MANCOVAs/MANOVAs that were signifi-
cant (p < .05) or tended toward significance (p < .1),
which was a means of minimizing the number of follow-
up comparisons, we did not strictly adjust for multiple
comparisons. As such, our results should be treated as
preliminary and warrant replication. Additionally, given
that our control sample was limited, we could not assess
group-by-genetic polymorphism interactions on brain
morphometry, which is recommended in similar studies.
Conclusion
In this study, we noted slightly smaller right pallidum vol-
umes in S/LA heterozygotes versus S/S homozygotes when
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groups were collapsed, suggesting an influence of 5-
HTTLPR on pallidum volume. The most pronounced 5-
HTTLPR genotype effects emerged when the MDD group
was assessed independently. Greater left thalamus and pu-
tamen volumes were found in LA/LA homozygotes, con-
sistent with hypotheses. These data point to the possibility
that 5-HT activity alterations may be associated with mor-
phometric changes in regions implicated in emotional and
reward processing in MDD. No 5-HTTLPR genotype ef-
fects existed on cortical thickness; the same was true for
the Val66Met polymorphism. Given that genetic imaging
studies require large samples, multicentre involvement
and data sharing will go a long way in advancing this field
in the future.
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